Medical News

RSS

$Reformulated epileptic drug reaches first clinical trial for medically refractory epilepsy$

Reformulated epileptic drug reaches first clinical trial for medically refractory epilepsy

A currently approved epileptic drug to treat seizures has been modified by a University of Colorado Anschutz Medical Campus professor and is currently being used in a clinical trial in Australia for medically refractory epilepsy.

4 Apr 2019

Research identifies first case of a person without vitamin D binding protein

Research identifying the first case of a person living without the protein needed to bind and transport vitamin D in the bloodstream has been published in the New England Journal of Medicine.

4 Apr 2019

Moderate drinking does not protect against stroke, new study shows

Blood pressure and stroke risk increase steadily with increasing alcohol intake, and previous claims that 1-2 alcoholic drinks a day might protect against stroke are dismissed by new evidence from a genetic study involving 160,000 adults.

4 Apr 2019

AACR Annual Meeting 2019 Highlighted Latest Advances in Cancer Research

On Friday, March 29 to Wednesday, April 3, the Georgia World Congress Center in Atlanta, Georgia, hosted the AACR Annual Meeting 2019.

From 10x Genomics, Inc. 4 Apr 2019

Eyelids often missed when applying sunscreen, increasing skin cancer risk

A new study has found that people who apply a moisturizer containing SPF or sunscreen may be missing the facial areas that are most at risk of developing skin cancer.

4 Apr 2019

Study offers new hope for patients with decompensated cirrhosis

Decompensated cirrhosis is a chronic disease linked to numerous complications in its final stage. Professor Jonel Trebicka from Goethe University was involved in carrying out a pilot study demonstrating that the long-term administration of albumin in high doses stabilizes the circulatory function of these patients and protects them from sepsis.

4 Apr 2019

Low fiber, high salt diets responsible for one in five deaths worldwide

According to a new study, poor diet is the greatest risk factor for dying early and causes one in five deaths.

4 Apr 2019

Ground-breaking research helps better understand the threat posed by antifungal drug resistance

Ground-breaking work by university experts in Tennessee, Texas and Swansea is helping develop a better understanding of the growing threat posed by antifungal drug resistance.

4 Apr 2019

DBS improves patients' cognitive control by increasing power of brain rhythms

In a new study that could improve the therapeutic efficacy of deep-brain stimulation for psychiatric disorders such as depression, a team of scientists shows that, when DBS is applied to a specific brain region, it improves patients' cognitive control over their behavior by increasing the power of a specific low-frequency brain rhythm in their prefrontal cortex.

4 Apr 2019

New genetic information behind urogenital track anomalies uncovered

About one in every 100 babies is born with some kind of developmental anomaly in the urogenital tract. In most cases abnormalities are mild, but sometimes life-long and even life-threatening disease develops.

4 Apr 2019

UB researchers develop new method to more accurately predict tumor growth rates

University at Buffalo researchers have developed a new method to more accurately predict tumor growth rates, a crucial statistic used to schedule screenings and set dosing regimens in cancer treatment.

4 Apr 2019

Medical students improve Wikipedia articles on skin-related diseases

A group of medical students recruited to improve Wikipedia articles on skin-related diseases, saw millions more views of those stories following their editing, highlighting the value of expert input on the popular web encyclopedia.

4 Apr 2019

Polypharmacy in old age increases risk of adverse side effects

As people get older, the more likely they are to take several different medicines on a regular basis. However, this increases the risk of adverse effects, including interactions between the various active agents.

4 Apr 2019

Bronchiectasis patients often display high sensitivity to airborne allergens

An international research team led by Nanyang Technological University, Singapore (NTU Singapore) has found that patients with the lung disease bronchiectasis also often display sensitivity to airborne allergens, and has highlighted the particular role that fungi appear to play.

4 Apr 2019

LINX Reflux Management System reduces medical costs for GERD and other health problems

Treatment with Ethicon’s LINX Reflux Management System reduced medical costs more than laparoscopic Nissen fundoplication, a more invasive anti-reflux surgery, and more than offsets the slightly higher cost of the procedure, according to a new study presented here today at the 2019 Annual Meeting of the Society of American Gastrointestinal and Endoscopic Surgeons.

From Johnson & Johnson 4 Apr 2019

Government subsidies could be key to reducing healthcare-associated infections

Healthcare-associated infections -- illnesses that people contract while being treated in a hospital or other healthcare facility -- sicken millions of people each year and cost billions of dollars in additional treatment.

4 Apr 2019

New study could improve methods for detecting congenital heart disease

A new study by biomedical engineering researchers at the University of Arkansas could significantly improve methods for detecting and diagnosing congenital heart disease in infants and small children.

4 Apr 2019

Developing imaging techniques for early detection of eye and brain diseases

The eyes may be the window to the soul, but to scientists, they are also the window to the brain. In particular, the retina, a delicate light-sensing neural network with specialized cells at the back of the eyeball, is linked directly to the brain via the optic nerve and is considered by some to be part of the brain itself.

4 Apr 2019

Opioid epidemic fuels growing rates of some infectious diseases

The United States faces a converging public health crisis as the nation's opioid epidemic fuels growing rates of certain infectious diseases, including HIV/AIDS, hepatitis, heart infections, and skin and soft tissue infections.

4 Apr 2019

NIAID awards $22 million grant to develop antibody-based therapies against lethal viruses

The National Institute of Allergy and Infectious Diseases has awarded an international consortium led by Albert Einstein College of Medicine, part of Montefiore, a five-year, $22 million grant to develop antibody-based therapies against four highly lethal viruses for which there are no approved vaccines or treatments.

4 Apr 2019